GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandion Oncology A/S (OSTO:SCOL) » Definitions » Price-to-Funds-From-Operations

Scandion Oncology A/S (OSTO:SCOL) Price-to-Funds-From-Operations : (As of Jun. 07, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Scandion Oncology A/S Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Scandion Oncology A/S (OSTO:SCOL) Business Description

Traded in Other Exchanges
Address
Fruebjergvej 3, Symbion, Copenhagen, DNK, 2100
Scandion Oncology A/S is a clinical-stage biotechnology company developing first-in-class medicines aimed at treating cancer that is resistant to current treatment options. Cancer Drug Resistance Company discovers and develops first-in-class medicines aimed at treating cancer that is resistant to current treatment options.